Insulin tregopil clinical trials
Also written IN-105.
How each study uses insulin tregopil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Biocon Limited (4)
Studies
Open first, then newest update. How each study uses insulin tregopil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin TregopilTerminatedPhase 1Biocon LimitedNCT04141423Written as Tregopil
- Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus PatientsCompletedPhase 2/3Biocon LimitedNCT03430856Written as Insulin Tregopil
- Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PDCompletedPhase 1Biocon LimitedNCT03392961Written as IN-105 (Insulin Tregopil)
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes PatientsTerminatedPhase 1Biocon LimitedNCT01035801Written as IN-105
Codes
What other systems call insulin tregopil · ClinicalTrials.gg INT014739
- UNII (FDA) 3UYC0OZ5ONINSULIN TREGOPILOne source FDA
- NCI Thesaurus C166701Insulin TregopilOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 3UYC0OZ5ON | INSULIN TREGOPIL | One source FDA |
| NCI Thesaurus | C166701 | Insulin Tregopil | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.